The topoisomerase I inhibitor DX-8951f is a poor substrate for the breast cancer resistance protein (2005)
Hattum, A.H. Van,
Hoogsteen, I.J.,
Schlüper, H.M.M.,
Maliepaard, M.,
Scheffer, G.L.,
Scheper, R.J.,
...
Induction of breast cancer resistance protein by the camptothecin derivative DX-895f is associated with minor reduction of antitumour activity (2004)
Hattum, A.H. Van,
Hoogsteen, I.J.,
Schlüper, H.M.M.,
Maliepaard, M.,
Scheffer, G.L.,
Scheper, R.J.,
...
VEGF165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts (2002)
Duyndam, M.C.A.,
Schlüper, H.M.M.,
Verheul, H.M.W.,
Kraal, G.,
Pinedo, H.M.,
...
The activity profile of the hexacyclic camptothecin derivative DX-8951f in experimental human colon cancer and ovarian cancer (2002)
Hattum, A.H. Van,
Pinedo, H.M.,
Schlüper, H.M.M.,
Erkelens, C.A.M.,
Tohgo, A.,
Boven, E.
Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system (2000)
Kolfschoten, G.M.,
Pinedo, H.M.,
Scheffer, P.G.,
Schlüper, H.M.M.,
Erkelens, C.A.M.,
Boven, E.
Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system (2000)
Kolfschoten, G.M.,
Pinedo, H.M.,
Scheffer, P.G.,
Schlüper, H.M.M.,
Erkelens, C.A.M.,
Boven, E.